免疫治疗癫痫27例临床观察

TREATMENT OF EPILEPSY WITH IMMUNOTHERAPY (CLINICAL OBSERVATION ON 27 CASES)

本文报告用国产人血球蛋白(我们采用的人血球蛋白属于NTGG)治疗27例癲痫患者的临床疗效。其中男15例,女12例;年龄最小3岁,最大20岁;病程0.5～16年。经治疗显效者12例,好转者13例,总有效率为92％。对照组中,10例患者用安定治疗,有效率为80％;另10例患者用卡马西平治疗,有效率为70％。说明癫痫的免疫治疗优于用安定和卡马西平对癲痫的治疗。因此,免疫疗法是一种行之有效的方法,它为治疗癫痫开辟了新的途径。

Authors report the immunotherapeutic result of 27 cases of epilepsy treated with crude human γ-globulin. Among the patients, there were 15 males and 12 females, their ages were ranged from 3 to 20 years old and course of disease from 0.5 to 16 years. The curative effect could be devided into the following 3 categories: 1. markedly improvement. 12 caseS; 2. improvement; 13 casesj 3. ineffective! 2 cases. The total effective rate was 92%.In control group,valium therapy were used on 10 patients; CBZ were used on another 10 patients; the effective rates were 80%and 70% respectively.lt is considered that the immunotherapeutic effect is much higher than valium and CBZ. Therefore, we suggest that immunotherapy is a new way for treating the epilepsies.